Affiliation:
1. Xuzhou Medical University, Xuzhou 221002, Jiangsu, China
2. Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
Abstract
The Ras association domain family 10(RASSF10), a tumor suppressor gene, is located on human
chromosome 11p15.2, which is one of the members homologous to other N-terminal RASSF families obtained
through structural prediction. RASSF10 plays an important role in inhibiting proliferation, invasion, and migration,
inducing apoptosis, making cancer cells sensitive to docetaxel, and capturing G2/M phase. Some studies
have found that RASSF10 may inhibit the occurrence and development of tumors by regulating Wnt/β-catenin,
P53, and MMP2. Methylation of tumor suppressor gene promoter is a key factor in the development and progression
of many tumors. Various methylation detection methods confirmed that the methylation and downregulation
of RASSF10 often occur in various tumors, such as gastric cancer, lung cancer, colon cancer, breast
cancer, and leukemia. The status of RASSF10 methylation is positively correlated with tumor size, tumor type,
and TNM stage. RASSF10 methylation can be used as a prognostic factor for overall survival and disease-free
survival, and is also a sign of tumor diagnosis and sensitivity to docetaxel chemotherapy. In this review, we
mainly elucidate the acknowledged structure and progress in the verified functions of RASSF10 and the probably
relevant signaling pathways.
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Pharmacology,Molecular Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献